Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
A-DERMA is a pioneering dermo-cosmetic brand specializing in plant-based dermatology, specifically utilizing the unique properties of Rhealba Oat. Founded by Pierre Fabre, the company focuses on developing skincare solutions for fragile and sensitive skin, including conditions like atopic dermatitis and eczema. Their product range is built on extensive botanical research and clinical testing to ensure high tolerance and efficacy. A-DERMA's flagship lines, such as Exomega Control, are widely recommended by dermatologists globally for skin barrier repair and soothing. The brand operates as a key division within the Pierre Fabre Group, maintaining a strong commitment to sustainable sourcing and Clean & Green beauty standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on A-DERMA.